Physician

Mark Sittig, MD

According to 2025 Medicare claims, Mark Sittig, MD (NPI: 1275951519) practices radiation oncology in the Nashville-Davidson--Murfreesboro--Franklin, TN market, with the plurality of this provider's patient population coming from Williamson, TN. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY,PLLC (NPI: 1164595070; TIN: 62-1647259) and primary practice location at 37205-2031.

Sittig's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 227 traditional Medicare patients, billed 5,142 HCPCS/CPT codes, and received $747,915 in Medicare payments. The top billing code was 77338 (Design and construction of radiation treatment device for high precision radiation therapy). Part D data shows 136 prescription claims across 61 beneficiaries totaling $1,971 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 6 records totaling $711. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,209 to $747,915. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,589 and ending at $1,971. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$374K$748K2019 Medicare payment: $17,209 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $89,747 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $122,683 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $304,424 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $235,899 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $747,915 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201973261$17,209
20202751,433$89,747
20212621,868$122,683
20222214,181$304,424
20232052,671$235,899
20242275,142$747,915

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$22K2015 Drug cost: $10,589 (USD; Tot_Drug_Cst)2016 Drug cost: $7,934 (USD; Tot_Drug_Cst)2017 Drug cost: $21,570 (USD; Tot_Drug_Cst)2018 Drug cost: $524 (USD; Tot_Drug_Cst)2019 Drug cost: $624 (USD; Tot_Drug_Cst)2020 Drug cost: $1,706 (USD; Tot_Drug_Cst)2021 Drug cost: $2,706 (USD; Tot_Drug_Cst)2022 Drug cost: $2,112 (USD; Tot_Drug_Cst)2023 Drug cost: $2,304 (USD; Tot_Drug_Cst)2024 Drug cost: $1,971 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201533173$10,589
20163593$7,934
20173266$21,570
20181725$524
20191822$624
20205089$1,706
202152103$2,706
202255103$2,112
202354105$2,304
202461136$1,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77338Design and construction of radiation treatment device for high precision radiation therapy6177$163
77263Complex radiation therapy planning6568$120
77334Design and construction of complex radiation treatment device67108$43
77014Ct guidance for insertion of radiation therapy fields78817$32
77300Calculation of radiation therapy dose67228$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl463,225$723
Oxybutynin Chloride ErOxybutynin Chloride18765$262
Mometasone FuroateMometasone Furoate12238$182
GabapentinGabapentin14341$135

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$711Janssen Scientific Affairs, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark Sittig, MD?

Tedicare shows public-source Medicare data for Mark Sittig, MD (NPI 1275951519), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Sittig, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Sittig, MD?

Mark Sittig, MD is linked to TENNESSEE ONCOLOGY,PLLC (billing NPI 1164595070) in the available physician profile data.

Does Mark Sittig, MD have Open Payments data?

Mark Sittig, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.